276 related articles for article (PubMed ID: 28084616)
1. Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
Adler NR; McLean CA; Aung AK; Goh MS
Clin Exp Dermatol; 2017 Apr; 42(3):299-302. PubMed ID: 28084616
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
Baltazard T; Dhaille F; Duvert-Lehembre S; Lok C; Chaby G
Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469749
[TBL] [Abstract][Full Text] [Related]
3. A toxic epidermal necrolysis-like presentation of linear IgA bullous dermatosis treated with dapsone.
Nguyen JK; Koshelev MV; Gill BJ; Boulavsky J; Diwan AH; Dao H
Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469740
[TBL] [Abstract][Full Text] [Related]
4. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature.
Kakar R; Paugh H; Jaworsky C
Dermatology; 2013; 227(3):209-13. PubMed ID: 24135381
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced linear IgA bullous dermatosis simulating toxic epidermal necrolysis.
Nasr J; Ammoury A; Chouairy C; Mégarbané H; El Habr C
J Med Liban; 2014; 62(3):176-9. PubMed ID: 25306799
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome.
Jones DH; Todd M; Craig TJ
J Am Osteopath Assoc; 2004 Apr; 104(4):157-63. PubMed ID: 15127983
[TBL] [Abstract][Full Text] [Related]
7. Linear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome.
Park JS; Hamilton CD; Patel S; Lee JB; Hsu S
Cureus; 2022 Oct; 14(10):e30309. PubMed ID: 36381872
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis.
Pereira AR; Moura LH; Pinheiro JR; Pasin VP; Enokihara MM; Porro AM
An Bras Dermatol; 2016; 91(5 suppl 1):35-38. PubMed ID: 28300888
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.
Lammer J; Hein R; Roenneberg S; Biedermann T; Volz T
Acta Derm Venereol; 2019 May; 99(6):508-515. PubMed ID: 30809685
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
Waldman MA; Black DR; Callen JP
Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report.
Cummings JE; Snyder RR; Kelly EB; Raimer SS
Cutis; 2007 Mar; 79(3):203-7. PubMed ID: 17674585
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin-Tazobactam-Induced Linear IgA Bullous Dermatosis Supported by a T-Cell Activation Assay.
Ho YH; Chiu YW; Liu HN
Ann Dermatol; 2018 Oct; 30(5):588-591. PubMed ID: 33911483
[TBL] [Abstract][Full Text] [Related]
13. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin-332.
Zenke Y; Nakano T; Eto H; Koga H; Hashimoto T
Br J Dermatol; 2014 Apr; 170(4):965-9. PubMed ID: 24641255
[TBL] [Abstract][Full Text] [Related]
14. Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
Tomida E; Kato Y; Ozawa H; Hasegawa H; Ishii N; Hashimoto T; Akiyama M
Br J Dermatol; 2016 Nov; 175(5):1106-1108. PubMed ID: 26265104
[No Abstract] [Full Text] [Related]
15. A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
Adachi M; Adachi T; Yokota M; Ichimura C; Yoshida K; Ishii K; Ishiko A
J Dermatol; 2021 Dec; 48(12):e610-e611. PubMed ID: 34561902
[No Abstract] [Full Text] [Related]
16. Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.
Garel B; Ingen-Housz-Oro S; Afriat D; Prost-Squarcioni C; Tétart F; Bensaid B; Bara Passot C; Beylot-Barry M; Descamps V; Duvert-Lehembre S; Grootenboer-Mignot S; Jeudy G; Soria A; Valnet-Rabier MB; Barbaud A; Caux F; Lebrun-Vignes B
Br J Clin Pharmacol; 2019 Mar; 85(3):570-579. PubMed ID: 30511379
[TBL] [Abstract][Full Text] [Related]
17. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms.
Chanal J; Ingen-Housz-Oro S; Ortonne N; Duong TA; Thomas M; Valeyrie-Allanore L; Lebrun-Vignes B; André C; Roujeau JC; Chosidow O; Wolkenstein P
Br J Dermatol; 2013 Nov; 169(5):1041-8. PubMed ID: 23815152
[TBL] [Abstract][Full Text] [Related]
18. Case of shift from linear immunoglobulin A bullous dermatosis to pemphigus herpetiformis for a short period of time.
Koga H; Ishii N; Hashimoto T; Nakama T
J Dermatol; 2017 Feb; 44(2):189-193. PubMed ID: 28497856
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin-induced linear IgA bullous dermatosis: associations.
Gameiro A; Gouveia M; Tellechea O; Goncalo M
Dermatol Online J; 2016 Apr; 22(4):. PubMed ID: 27617457
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
Dellavalle RP; Burch JM; Tayal S; Golitz LE; Fitzpatrick JE; Walsh P
J Am Acad Dermatol; 2003 May; 48(5 Suppl):S56-7. PubMed ID: 12734475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
